The main purpose of this Manual is to provide useful guidelines for the selection of pathology tests and to facilitate interpretation of results.
Contains a comprehensive listing of all genes from the Human Gene Nomenclature Committee (HGNC) database alongside laboratories and tests available in the country.
A manual for the process of macroscopic dissection in Anatomical Pathology laboratories.
Donate online now using the button below. RCPA Foundation thanks you for your generous support. All funds raised will be allocated to the RCPA Foundation Pathology Education Outreach Fellowship.
Events and Sponsorship Manager
Ph: +61 2 8356 5806
Fax: +61 2 8356 5828
Events and Grants Coordinator
Ph: +61 2 8356 5852
Fax: +61 2 8356 5828
Keywords: Cytology cervical, Cytology gynae, Cervical cytology, Cytology pap smear, Pap, Cervical cytology - conventional sample
Obtained from cervical transition zone. If possible cervical transition zone should be well visualised before sampling.
Vaginal vault specimens taken following hysterectomy with a history of dysplasia or malignancy.
Choice of sampling device varies. Alternatives include wooden or plastic spatula, cervical or brush.
Brush samples may be indicated in peri or postmenopausal women or those with a previous history of glandular abnormality.
Rapid fixation of specimen is imperative, using either spray cytofixative or immersion in 95% ethanol.
As part of organised cervical screening programmes, women with no symptoms or history suggestive of cervical disease are screened every two years (Australia) or three years (New Zealand).
Age of commencement and cessation of screening vary between different organised programmes.
Women who have never had coitus do not need routine cervical smears.
Cervical cytology also recommended in the investigation of abnormal vaginal bleeding, especially intermenstrual bleeding or postcoital bleeding.
Cervical cytology is an insensitive diagnostic test for the diagnosis of cervical malignancy, and women with a significant history or abnormal cervical findings should be referred for further assessment regardless of cervical cytology results.
Cytology can detect and define squamous and glandular pre-malignancy (squamous intraepithelial lesion, adenocarcinoma in-situ).
Aim of organised cervical screening programmes is to detect high grade SIL and subsequently reduce the incidence of invasive cervical carcinoma.
Cervical cytology may also detect changes of invasive squamous carcinoma, invasive endocervical/endometrial adenocarcinoma.
Specific infections can also be identified on a smear: Candida, Trichomonas vaginalis, HSV and HPV, and changes of bacterial vaginosis.
The test is insensitive for the diagnosis of Chlamydia trachomatis infection.
Gray W and Kocjan G eds. Diagnostic Cytopathology. 3rd ed. 2010. Churchill Livingstone.
Solomon D and Nayer R. The Bethesda system for reporting cervical cytology. 2nd Ed. 2004. Springer.
Page last updated:
The RCPA is the leading organisation representing Pathologists and Senior Scientists in Australasia.
Its mission is to train and support pathologists and senior scientists and to improve the use of pathology testing to achieve better healthcare.
The annual scientific meeting for the RCPA which covers the scientific disciplines of Anatomical, Chemical, Forensic, Genetic, General, Haematology, Immunopathology and Microbiology.
Copyright © 2020 RCPA. All rights reserved.